APA (7th ed.) Citation

Bokemeyer, B., Plachta-Danielzik, S., Gilman, E., di Giuseppe, R., Deppe, H., Mohl, W., . . . Schreiber, S. (2025). Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn’s disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment. Journal of Crohn's and Colitis, 19(4), . https://doi.org/10.1093/ecco-jcc/jjaf051

Chicago Style (17th ed.) Citation

Bokemeyer, Bernd, et al. "Comparative Real-world Effectiveness of Ustekinumab Versus Anti-TNF in Crohn’s Disease: 12-month Maintenance Phase Results from the Prospective, Observational RUN-CD Study Using Propensity Score Adjustment." Journal of Crohn's and Colitis 19, no. 4 (2025). https://doi.org/10.1093/ecco-jcc/jjaf051.

MLA (9th ed.) Citation

Bokemeyer, Bernd, et al. "Comparative Real-world Effectiveness of Ustekinumab Versus Anti-TNF in Crohn’s Disease: 12-month Maintenance Phase Results from the Prospective, Observational RUN-CD Study Using Propensity Score Adjustment." Journal of Crohn's and Colitis, vol. 19, no. 4, 2025, https://doi.org/10.1093/ecco-jcc/jjaf051.